A systematic review of population screening for fragile X syndrome

被引:64
|
作者
Hill, Melissa K. [1 ,2 ]
Archibald, Alison D. [1 ,3 ]
Couns, Grad Dip Genet [1 ,3 ]
Cohen, Jonathan [4 ,5 ]
Metcalfe, Sylvia A. [1 ,3 ]
机构
[1] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia
[2] Hosp Children NHS Trust, Inst Child Hlth & Great Ormond St, London, England
[3] Univ Melbourne, Dept Paediat, Melbourne, Australia
[4] Fragile X Alliance Inc, Melbourne, Australia
[5] Monash Univ, Dept Gen Pract, Melbourne, Australia
基金
英国医学研究理事会;
关键词
attitudes; carrier screening; fragile X syndrome; newborn screening; psychosocial; POLYMERASE-CHAIN-REACTION; CGG REPEAT; MENTAL-RETARDATION; NONPREGNANT WOMEN; EXPANDED ALLELES; PREGNANT-WOMEN; NEWBORN MALES; BLOOD SPOTS; FMR1; GENE; ATTITUDES;
D O I
10.1097/GIM.0b013e3181e38fb6
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
To conduct a systematic review of literature regarding population-based screening for fragile X syndrome in newborns and women of reproductive age, either before or during pregnancy. Methods: Seven electronic databases were searched for English language studies published between January 1991 and November 2009. Data extraction was performed for all included studies. Results were synthesized using a narrative approach. Results: One article that examined offering newborn screening for fragile X syndrome and 10 that examined the offer of fragile X syndrome screening to women of reproductive age were identified. Two of these articles also addressed psychosocial aspects of population screening for fragile X syndrome such as attitudes to screening and experiences of screening, and a further nine addressed these issues alone. Studies exploring psychosocial issues demonstrated challenges for counseling arising from a lack of awareness or personal experience with fragile X syndrome in the general population. Conclusions: Targeted counseling and educational strategies will be essential to support women from the general population. It is crucial that future studies offering screening for fragile X syndrome explore a range of psychosocial aspects in addition to looking at uptake of testing and mutation frequency. Genet Med 2010: 12(7): 396-410.
引用
收藏
页码:396 / 410
页数:15
相关论文
共 50 条
  • [31] DNA analysis of the fragile X syndrome in an at risk pediatric population in Croatia: Simple clinical preselection criteria can considerably improve the cost-effectiveness of fragile X screening studies
    Hecimovic, S
    Barisic, I
    Pavelic, K
    HUMAN HEREDITY, 1998, 48 (05) : 256 - 265
  • [32] Behavior Problems and Social Competence in Fragile X Syndrome: A Systematic Review
    Cregenzan-Royo, Olga
    Brun-Gasca, Carme
    Fornieles-Deu, Albert
    GENES, 2022, 13 (02)
  • [33] Executive Function in Fragile X Syndrome: A Systematic Review
    Schmitt, Lauren M.
    Shaffer, Rebecca C.
    Hessl, David
    Erickson, Craig
    BRAIN SCIENCES, 2019, 9 (01)
  • [34] Systematic screening for fragile X syndrome in a cohort of 574 mentally retarded children
    Gerard, B
    LeHeuzey, MF
    Brunie, G
    Lewine, P
    Saiag, MC
    Cacheux, V
    DaSilva, F
    Dugas, M
    MourenSimeoni, MC
    Elion, J
    Grandchamp, B
    ANNALES DE GENETIQUE, 1997, 40 (03): : 139 - 144
  • [35] Economic evaluation of prenatal population screening for fragile X syndrome
    Hollingsworth, B
    Harris, A
    COMMUNITY GENETICS, 2005, 8 (02) : 68 - 72
  • [36] Informed decision making and psychosocial outcomes in pregnant and nonpregnant women offered population fragile X carrier screening
    Metcalfe, Sylvia A.
    Martyn, Melissa
    Ames, Alice
    Anderson, Vicki
    Archibald, Alison D.
    Carter, Rob
    Cohen, Jonathan
    Cotter, Megan
    Dang, William
    Delatycki, Martin B.
    Donath, Susan
    Edwards, Samantha
    Forbes, Robin
    Gavrila, Mioara
    Halliday, Jane
    Hickerton, Chriselle
    Hill, Melissa
    Jacobs, Lorilli
    Petrou, Vicki
    Plunkett, Loren
    Sheffield, Leslie
    Thornton, Alison
    Younie, Sandra
    Emery, Jon D.
    GENETICS IN MEDICINE, 2017, 19 (12) : 1346 - 1355
  • [37] Systematic review of pharmacological treatments in fragile X syndrome
    Rueda, Jose-Ramon
    Ballesteros, Javier
    Tejada, Maria-Isabel
    BMC NEUROLOGY, 2009, 9 : 53
  • [38] Fragile X-syndrome: Literature review and report of two cases
    Ridaura-Ruiz, Lourdes
    Quinteros-Borgarello, Milva
    Berini-Aytes, Leonardo
    Gay-Escoda, Cosme
    MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL, 2009, 14 (09): : E434 - E439
  • [39] Experiences of the Molecular Diagnosis of Fragile X Syndrome in Ecuador
    Pozo-Palacios, Juan
    Llamos-Paneque, Arianne
    Rivas, Christian
    Onofre, Emily
    Lopez-Caceres, Andrea
    Villareal, Jenniffer
    FRONTIERS IN PSYCHIATRY, 2021, 12
  • [40] Size and methylation mosaicism in males with Fragile X syndrome
    Jiraanont, Poonnada
    Kumar, Madhur
    Tang, Hiu-Tung
    Espinal, Glenda
    Hagerman, Paul J.
    Hagerman, Randi J.
    Chutabhakdikul, Nuanchan
    Tassone, Flora
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2017, 17 (11) : 1023 - 1032